- Home
- ORIC vs NUS Comparison
ORIC vs NUS Comparison
Compare ORIC & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- NUS
- Stock Information
- Founded
- ORIC 2014
- NUS 1984
- Country
- ORIC United States
- NUS United States
- Employees
- ORIC N/A
- NUS N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- NUS Other Pharmaceuticals
- Sector
- ORIC Health Care
- NUS Health Care
- Exchange
- ORIC Nasdaq
- NUS Nasdaq
- Market Cap
- ORIC 362.9M
- NUS 361.7M
- IPO Year
- ORIC 2020
- NUS 1996
- Fundamental
- Price
- ORIC $9.35
- NUS $7.77
- Analyst Decision
- ORIC Strong Buy
- NUS Hold
- Analyst Count
- ORIC 8
- NUS 2
- Target Price
- ORIC $18.83
- NUS $6.88
- AVG Volume (30 Days)
- ORIC 2.0M
- NUS 523.4K
- Earning Date
- ORIC 08-11-2025
- NUS 08-07-2025
- Dividend Yield
- ORIC N/A
- NUS 3.14%
- EPS Growth
- ORIC N/A
- NUS N/A
- EPS
- ORIC N/A
- NUS N/A
- Revenue
- ORIC N/A
- NUS $1,679,268,000.00
- Revenue This Year
- ORIC N/A
- NUS N/A
- Revenue Next Year
- ORIC N/A
- NUS N/A
- P/E Ratio
- ORIC N/A
- NUS N/A
- Revenue Growth
- ORIC N/A
- NUS N/A
- 52 Week Low
- ORIC $3.90
- NUS $5.32
- 52 Week High
- ORIC $14.67
- NUS $12.65
- Technical
- Relative Strength Index (RSI)
- ORIC 62.84
- NUS 50.52
- Support Level
- ORIC $8.85
- NUS $7.54
- Resistance Level
- ORIC $9.54
- NUS $8.51
- Average True Range (ATR)
- ORIC 0.74
- NUS 0.28
- MACD
- ORIC -0.07
- NUS -0.10
- Stochastic Oscillator
- ORIC 50.98
- NUS 11.32
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.